Top compounds associated with response to LILRA1


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.31 9e-10
mRNA OSI-930 GDSC1000 pan-cancer AAC 0.21 9e-10
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA cediranib CTRPv2 pan-cancer AAC 0.3 9e-09
mRNA PD318088 CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.17 4e-08
mRNA barasertib CTRPv2 pan-cancer AAC 0.17 6e-08
mRNA BIX02189 GDSC1000 pan-cancer AAC 0.17 1e-07
mRNA PF-573228 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA Pazopanib GDSC1000 pan-cancer AAC 0.18 3e-07
Download CSV